Carbaglu (carglumic acid) Coverage Criteria
Customize your policy alerts
Sign up for all UnitedHealthcare policy alerts
Know when UnitedHealthcare releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs prior authorization and reauthorization for Carbaglu in pediatric and adult patients with hyperammonemia associated with N-acetylglutamate synthase deficiency, propionic acidemia, or methylmalonic acidemia. Coverage requires an eligible diagnosis for initial authorization and documentation of positive clinical response for reauthorization.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.